0QF:FRA
Moderna Inc
170,82 €
arrow_upward
+1,12%(+1,90) 1D
2 ოქტ, 10:48:04 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
169,66 €
High
171,08 €
Low
169,66 €
Mkt. cap
75,43 მლრდ.
Avg. vol.
2,99 ათ.
Volume
692,00
52-wk high
183,40 €
52-wk low
19,26 €
No. of employees
5 ათ.
Open
169,66 €
High
171,08 €
Low
169,66 €
Mkt. cap
75,43 მლრდ.
Avg. vol.
2,99 ათ.
Volume
692,00
52-wk high
183,40 €
52-wk low
19,26 €
No. of employees
5 ათ.
News stories
From web sources and news partners
Investing.com
·
1 საათის წინ
Why is Moderna stock rallying today?
TipRanks
·
1 საათის წინ
Why Did Moderna Stock Gain (MRNA) in After-Hours Trading on Thursday?
Reuters
·
9 საათის წინ
Moderna to replace Warner Bros Discovery on Nasdaq 100
Yahoo Finance
·
9 საათის წინ
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
About Moderna Inc